These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 4282084

  • 21. Pathophysiology and modern management of Paget's disease.
    Ryan WG.
    Compr Ther; 1983 Sep; 9(9):64-9. PubMed ID: 6226475
    [Abstract] [Full Text] [Related]

  • 22. Newer agents in treating Paget's disease of bone.
    Goldfield EB.
    Geriatrics; 1974 Dec; 29(12):61-9. PubMed ID: 4279196
    [No Abstract] [Full Text] [Related]

  • 23. The treatment of Paget's disease.
    Berzims D.
    Aust Nurses J; 1979 Jun; 8(11):34-5. PubMed ID: 157732
    [No Abstract] [Full Text] [Related]

  • 24. [Problems in the diagnosis and treatment of Paget's disease].
    Zdichynec B.
    Fysiatr Revmatol Vestn; 1976 Jul; 54(3):113-7. PubMed ID: 134968
    [No Abstract] [Full Text] [Related]

  • 25. Calcitonin or mithramycin for Paget's disease.
    Russell AS.
    Lancet; 1980 Apr 19; 1(8173):884. PubMed ID: 6103247
    [No Abstract] [Full Text] [Related]

  • 26. Paget's disease of bone.
    Lukert BP.
    J Kans Med Soc; 1979 Jun 19; 80(6):345-8. PubMed ID: 156768
    [No Abstract] [Full Text] [Related]

  • 27. Dramatic response to plicamycin in a patient with severe Paget's disease refractory to calcitonin and pamidronate.
    Wimalawansa SJ.
    Semin Arthritis Rheum; 1994 Feb 19; 23(4):267. PubMed ID: 8009249
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of Paget's osteitis deformans].
    Brixen K, Steiniche T, Mosekilde L, Melsen F.
    Ugeskr Laeger; 1989 Mar 13; 151(11):677-80. PubMed ID: 2522692
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Clinical and metabolic effects of mithramycin and glucagon in the treatment of Paget's disease].
    Hadjipavlou AG, Danais S, Greenwood F, Siller TN, Tsoukas GM.
    Union Med Can; 1978 Sep 13; 107(9):849-56. PubMed ID: 151960
    [No Abstract] [Full Text] [Related]

  • 34. [Management of osteitis deformans--diphosphonate, calcitonin or mitramycin?].
    Tørring O.
    Lakartidningen; 1981 Aug 19; 78(34):2831-2. PubMed ID: 6459502
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Human calcitonin for Paget's disease.
    Med Lett Drugs Ther; 1987 May 08; 29(739):47-8. PubMed ID: 3574238
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of Paget's disease of bone.
    Melick RA.
    Med J Aust; 1985 Oct 28; 143(9):394-7. PubMed ID: 2932626
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.